DPY19L4

Across TCGA pan-cancer cohorts, DPY19L4 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated DPY19L4 data layer compared with 24 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher DPY19L4 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated DPY19L4 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

HNSC and LUAD are the cancer types where DPY19L4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	IV	0.945	0.665	.040	7	view →
LUAD	DFS	Quartile	All	0.428	1.000	.029	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DPY19L4–HNSC (DFS)

Open the HNSC breakdown →